植入式心脏除颤器患者的心房颤动

Atrial fibrillation in patients with implantable defibrillators.

作者信息

Sakhuja Rahul, Shah Ashok J, Keebler Mary, Thakur Ranjan K

机构信息

Massachusetts General Hospital, Division of Cardiology, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Cardiol Clin. 2009 Feb;27(1):151-61, ix-x. doi: 10.1016/j.ccl.2008.09.014.

DOI:10.1016/j.ccl.2008.09.014

PMID:19111771

Abstract

Atrial fibrillation (AF) is common in patients who have implantable defibrillators and presents some unique challenges and opportunities. AF burden can be assessed more accurately, allowing for evaluation of therapy efficacy (drugs or ablation). It remains to be shown whether home monitoring of defibrillators to detect and treat AF more quickly can reduce cardiovascular and stroke end points. One major goal will be to reduce inappropriate shocks from atrial fibrillation. Otherwise, the goals of therapy remain the same-reduction of symptoms (including heart failure exacerbation and inappropriate implantable cardioverter defibrillator therapies) by controlling rate or rhythm and anticoagulation for stroke prophylaxis.

摘要

心房颤动（AF）在植入式除颤器患者中很常见，带来了一些独特的挑战和机遇。房颤负荷可以更准确地评估，从而能够评估治疗效果（药物或消融）。通过家庭监测除颤器以更快地检测和治疗房颤是否能降低心血管和卒中终点事件，仍有待证实。一个主要目标将是减少房颤导致的不适当电击。否则，治疗目标保持不变——通过控制心率或心律以及抗凝预防卒中，减轻症状（包括心力衰竭加重和不适当的植入式心脏复律除颤器治疗）。